News > Pune-based Gennova Biopharmaceuticals’ mRNA vaccine gets DCGI nod
Pune-based Gennova Biopharmaceuticals’ mRNA vaccine gets DCGI nod
The Week | 29/06/2022 09:50 AM | Click to read full article
The Drugs Controller General of India (DCGI) on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.
While other mRNA vaccines require to be stored at sub-zero temperatures, Gennova's mRNA vaccine can be stored at 2-8 degrees.
